257
Views
27
CrossRef citations to date
0
Altmetric
Original Articles

Isolation and Identification of the 3-Hydroxy-5-hydroxymethyl-pyridinium Compound as a Novel Advanced Glycation End Product on Glyceraldehyde-related Maillard Reaction

&
Pages 930-932 | Received 12 Nov 2002, Accepted 25 Jan 2003, Published online: 22 May 2014

  • 1) Hayase, F., Recent development of 3-deoxyosone related maillard reaction products. Food Sci. Technol. Res., 6, 79-86 (2000).
  • 2) Baynes, J. W., and Thorpe, S. R., Glycoxidation and lipoxidation in atherogenesis. Free Radical. Biol. Med., 28, 1708-1716 (2000).
  • 3) Hayase, F., Scavenging of active oxygen by melanoidins. In “The Maillard Reaction”, ed. Ikan, R., Wiley, J., and Sons, Ltd., England, pp. 89-104 (1996).
  • 4) Friedman, M., Food browning and its prevention: An overview. J. Agric. Food Chem., 44, 631-653 (1996).
  • 5) Lehmann, R., and Schleicher, E. D., Molecular mechanism of diabetic nephropathy. Clinica Chimica Acta, 297, 135-144 (2000).
  • 6) Friedman, E. A., Advanced glycation end-products in diabetic nephropathy. Nephrol. Dial. Transplant., 14, 1-9 (1999).
  • 7) Finch, C. E., and Cohen, D. M., Aging, metabolism, and Alzheimer disese—review and hypotheses. Exp. Neurol., 143, 82-102 (1997).
  • 8) Loske, C., Neumann, A., Cunningham, A. M., Nichol, K., Schinzel, R., Riederer, P., and Munch, G., Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J. Neural Transm., 105, 1005-1015 (1998).
  • 9) Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., Koike, T., Wakayama, I., Yanagihara, R., Garruto, R., Amano, N., and Makita, Z., Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am. J. Pathol., 153, 1149-1155 (1998).
  • 10) Castellani, R., Smith, M. A., Richey, P. J., and Petty, G., Glycoxidation and oxidative stress in Parkinson's disease and diffuse Lewy body disease. Brain Res., 737, 195-200 (1996).
  • 11) Chou, S. M., Wang, H. S., Taniguchi, A., and Bucala, R., Advanced glycation end products in neurofilament conglomeration of motoneurons in familial and sporadic amyofrophic lateral sclerosis. Mol. Med., 4, 324-332 (1998).
  • 12) Takeuchi, M., Bucala, R., Suzuki, T., Ohkubo, T., Yamazaki, M., Koike, T., Kameda, Y., and Makita, Z., Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J. Neuropathol. Exp. Neurol., 59, 1094-1105 (2000).
  • 13) Yamagishi, S., Inagaki, Y., Okamoto,T., Amano, S., Koga, K., Takeuchi, M., and Makita, Z., Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human cultured mesangial cells. J. Biol. Chem., 277, 20309-20315 (2002).
  • 14) Kato, H., Kaneko, S., Okitani, A., Ito, M., and Hayase, F., Modification of lysine residues to alkyl-substituted pyridiniums on exposure of proteins to vaporized hexanal. Agric. Biol. Chem., 50, 1223-1228 (1986).
  • 15) Hayase, F., Hinuma, H., Asano, M., Kato, H., and Arai, S., Identification of novel fluorescent pyrrolopyridinium compound formed from maillard reaction of 3-deoxyglucosone and butylamine. Biosci. Biotechnol. Biochem., 58, 1936-1937 (1994).
  • 16) Nagai, R., Hayashi, C. M., Xia, L., Takeya, M., and Horiuchi, S., Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J. Biol. Chem., 277, 48905-48912 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.